Dondonx2, I pretty much agree with this sentiment specifically to HGEN. The big players have been allowed to push the retail holders around and have scared most away, giving the big holders further control. This way they could load up if they feel strongly about P3 trial results. The longs on this board have the scars.
That said, HGEN is up about 60% since September, though it hasn't been an easy ride. To be straight, we have seen delays, but I believe the derisked P3 trial is worth the wait.
I think this is a paraphrase of a Warren Buffet quote:
In the short term, the stock market works as a voting machine, but in the long term the stock market works as a weighing machine.
I'm here to ride HGEN from criminally undervalued to hopefully crazy overvalued. I'll settle for fairly valued -> $75.